We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Protected Geographical Indication (PGI)
Protected wine name with Protected Designation of Origin (PDO)
American viticultural area
Protected food name with Protected Designation of Origin (PDO)
Product Recall for NassifMD Deco-Lift Neck Firming Complex Serum presenting a health risk.
Product recall for Missguided Right Now Brow Thickening Brow Gel presenting a microbiological risk due to contamination.
Decision on application for authorisation under UK REACH.
The Medicines and Healthcare products Regulatory Agency (MHRA) has today (29 January 2024) approved the medicine Rezzayo (rezafungin) to treat a fungal infection called invasive candidiasis.
Information on how the 2019 voluntary scheme for branded medicines pricing and access is controlling spend on branded medicines in the NHS.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).